Dr. Hsu, inventor of iPill, speaks about how this device could transform opioid treatment plans by securing delivery to patients.
Episode 3 – Secure Medication Dispenser iPill with Dr. John Hsu
read more
Posts by Bruce Bassi
Episode 2 – Mind Bank Emil Jimenez on Digital Twins
Mind Bank’s founder, Emil Jimenez, talks about the concept of a digital twin, how it works, why it’s needed & impact on psychiatry.
CDC Updates Opioid Prescribing Guidelines in 2022
Updated CDC guidelines had intended to reverse more restrictive 2016 guidelines pertaining to opioid prescribing for acute and chronic pain.
Episode 1 – Maggi Savin-Baden on Digital Immortality
Professor Maggi Savin-Baden speaks about virtual reality in psychiatry and the digital afterlife.
Heart medication spironolactone shows potential for treatment of alcohol use disorder
New research shows spironolactone could be considered as another tool for treating alcohol use in populations with end stage liver disease. Study finds that individuals who are taking more than 50 milligrams of…
Wearable Devices for Mental Wellness
Wearables are becoming more popular than ever before. They’re helping people live healthier lives by monitoring their physical activity, sleep patterns, and even their moods.
Virtual Reality for Mental Health
Virtual reality is a potential way to help people overcome mental illness. It can be used to treat anxiety, depression, and PTSD.
Artificial Intelligence In Psychiatry
Artificial Intelligence (AI) has been used in healthcare for decades but its potential is only now being realized. Learn about the latest developments in AI and what they mean for mental healthcare.
Dr. Bassi Presentation on Sleep 8/5/22 @ 12:00 pm EST
This presentation will explore myths and misconceptions related to sleep, the importance of sleep on mental health, the impact of various illicit substances on sleep, and a general overview of treatment options for sleep with a special emphasis on cooccurring substance use disorders.
Updates in Treatment Resistant Depression
Updates to treatment resistant depression at the APA conference in New Orleans, LA.